)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Shijiazhuang Yiling Pharmaceutical
Shijiazhuang Yiling Pharmaceutical (002603) investor relations material
Shijiazhuang Yiling Pharmaceutical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary28 Apr, 2026
Executive summary
Achieved revenue of ¥7.83 billion in 2025, up 20.24% year-over-year; net profit attributable to shareholders was ¥1.29 billion, a 277.56% increase year-over-year.
Operating cash flow reached ¥1.78 billion, up 190.75% year-over-year.
Major product lines include patented Chinese medicines, chemical pharmaceuticals, and health products, with strong performance in cardiovascular and respiratory segments.
Maintained high R&D investment at ¥788 million, representing 10.07% of revenue.
Proposed total cash dividend payout of ¥1.34 billion, exceeding net profit for the year.
Financial highlights
Revenue: ¥7.83 billion (+20.24% YoY); net profit: ¥1.29 billion (+277.56% YoY).
Gross margin for main products: cardiovascular 68.60%, respiratory 75.16%.
Operating cash flow: ¥1.78 billion (+190.75% YoY).
Basic and diluted EPS: ¥0.77 (vs. -¥0.43 last year).
R&D expense: ¥788 million (10.07% of revenue).
Outlook and guidance
Will continue to strengthen core product promotion, expand into new therapeutic areas, and accelerate new drug launches.
Plans to optimize cost structure, enhance digital marketing, and maintain high R&D investment.
Expects continued growth in cardiovascular, respiratory, and health product segments.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Shijiazhuang Yiling Pharmaceutical
- Net profit surged 25.43% year-over-year on higher revenue and robust operating cash flow.002603
Q1 202629 Apr 2026 - 2024 net loss driven by sales drop, inventory write-downs, and high R&D; cost control prioritized.002603Q4 202422 Dec 2025
- Net profit soared 80.33% to ¥1.00 billion despite a 7.82% revenue decline.002603Q3 202528 Oct 2025
- Net profit rose 26% to ¥669 million despite a 12% revenue drop, with strong cash flow.002603Q2 202528 Aug 2025
- Revenue and profit declined sharply year-over-year, but operating cash flow improved.002603Q3 202413 Jun 2025
- Revenue and profit declined sharply, but R&D and market leadership in core products remain strong.002603Q2 202413 Jun 2025
- Net profit grew 7.25% year-over-year in Q1 2025 despite a 6.52% revenue drop.002603Q1 20256 Jun 2025
Next Shijiazhuang Yiling Pharmaceutical earnings date
Q2 202628 Aug, 2026
Shijiazhuang Yiling Pharmaceutical
Next Shijiazhuang Yiling Pharmaceutical earnings date
Q2 202628 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage